Back

Panel discussion.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: When is the time to implement novel biomarkers routinely? Biomarkers ESC Professional Premium Access ESC Congress 2022

3 More presentations in this session

Presentation thumbnail
State of the art lecture - when is the time to implement novel biomarkers routinely?
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population
Mr Z. Lu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover
Doctor J. Melgarejo (Leuven, BE)
Abstract Slides Video

Access the full session

Session thumbnail
When is the time to implement novel biomarkers routinely?
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Biomarkers profiles to identify new targets
thumbnail
Congress Session
Biomarkers in the era of 'OMICS': potential beyond diagnosis
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources